enGene Therapeutics Inc. Common Stock (ENGN) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for ENGN. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 60 institutions reported holding ENGN, with 50.0 million shares worth $86.5 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Fcpm III Services B.V | 9,632,561 | $17M | UNCHANGED |
| Bml Capital Management | 6,669,908 | $12M | NEW |
| Siren, | 6,256,662 | $11M | INCREASED |
| Perceptive Advisors | 4,822,169 | $8M | DECREASED |
| Ameriprise Financial | 2,675,876 | $5M | NEW |
Full institutional holdings, insider history, and congressional trades for enGene Therapeutics Inc. Common Stock on SentiSense.